grazax 75.000 sq.t frysetørret sublingual tablet
orifarm a/s - engrottehale (græspollenallergen) - frysetørret sublingual tablet - 75.000 sq.t
alk (108) betula verrucosa 450.000 sq-u/htgl pulver og solvens til injektionsvæske, opløsning
alk-abello a/s - betula verrucosa ehrh. (vortebirk, synonym af b. pendula roth) - pulver og solvens til injektionsvæske, opløsning - 450.000 sq-u/htgl
aitgrys 100+300 ri resoribletter, sublinguale
stallergenes sa - almindelig hundegræs (græspollenallergen), almindelig rajgræs (græspollenallergen), engrapgræs (græspollenallergen), engrottehale (græspollenallergen), vellugtende gulaks (græspollenallergen) - resoribletter, sublinguale - 100+300 ri
aitgrys 300 ri resoribletter, sublinguale
stallergenes sa - almindelig hundegræs (græspollenallergen), almindelig rajgræs (græspollenallergen), engrapgræs (græspollenallergen), engrottehale (græspollenallergen), vellugtende gulaks (græspollenallergen) - resoribletter, sublinguale - 300 ri
grazax 75.000 sq.t frysetørret tablet
medartuum ab - engrottehale (græspollenallergen) - frysetørret tablet - 75.000 sq.t
grazax 75.000 sq.t frysetørret sublingual tablet
abacus medicine a/s - engrottehale (græspollenallergen) - frysetørret sublingual tablet - 75.000 sq.t
suvaxyn circo+mh rtu
zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inaktiveret virus og bakterier inaktiverede vacciner - svin - til aktiv immunisering af svin fra 3 ugers alderen mod porcine circovirus type 2 (pcv2) for at reducere viral belastning i blod og lymfoide væv og fækalt afgivelse forårsaget af infektion med pcv2. til aktiv immunisering af svin over 3 uger mod mycoplasma hyopneumoniae for at reducere lungelæsioner forårsaget af infektion med m. hyopneumoniae.
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - svin - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
rotstop wp vanddispergerbart pulver
verdera oy - phlebiopsis - vanddispergerbart pulver - 2000000000 cfu/kg phlebiopsis gigantea stamme vra 1835
rotstop vanddispergerbart pulver
danstar ferment ag - phlebiopsis - vanddispergerbart pulver - 2000000000 cfu/kg phlebiopsis gigantea stamme vra 1835